Genetic Risk Can Be Decreased: Quitting Smoking Decreases and Delays Lung Cancer for Smokers With High and Low CHRNA5 Risk Genotypes — A Meta-Analysis

نویسندگان

  • Li-Shiun Chen
  • Timothy Baker
  • Rayjean J. Hung
  • Amy Horton
  • Robert Culverhouse
  • Sarah Hartz
  • Nancy Saccone
  • Iona Cheng
  • Bo Deng
  • Younghun Han
  • Helen M. Hansen
  • Janet Horsman
  • Claire Kim
  • Albert Rosenberger
  • Katja K. Aben
  • Angeline S. Andrew
  • Shen-Chih Chang
  • Kai-Uwe Saum
  • Hendrik Dienemann
  • Dorothy K. Hatsukami
  • Eric O. Johnson
  • Mala Pande
  • Margaret R. Wrensch
  • John McLaughlin
  • Vidar Skaug
  • Erik H. van der Heijden
  • Jason Wampfler
  • Angela Wenzlaff
  • Penella Woll
  • Shanbeh Zienolddiny
  • Heike Bickeböller
  • Hermann Brenner
  • Eric J. Duell
  • Aage Haugen
  • Irene Brüske
  • Lambertus A. Kiemeney
  • Philip Lazarus
  • Loic Le Marchand
  • Geoffrey Liu
  • Jose Mayordomo
  • Angela Risch
  • Ann G. Schwartz
  • M. Dawn Teare
  • Xifeng Wu
  • John K. Wiencke
  • Ping Yang
  • Zuo-Feng Zhang
  • Margaret R. Spitz
  • Christopher I. Amos
  • Laura J. Bierut
چکیده

BACKGROUND Recent meta-analyses show that individuals with high risk variants in CHRNA5 on chromosome 15q25 are likely to develop lung cancer earlier than those with low-risk genotypes. The same high-risk genetic variants also predict nicotine dependence and delayed smoking cessation. It is unclear whether smoking cessation confers the same benefits in terms of lung cancer risk reduction for those who possess CHRNA5 risk variants versus those who do not. METHODS Meta-analyses examined the association between smoking cessation and lung cancer risk in 15 studies of individuals with European ancestry who possessed varying rs16969968 genotypes (N=12,690 ever smokers, including 6988 cases of lung cancer and 5702 controls) in the International Lung Cancer Consortium. RESULTS Smoking cessation (former vs. current smokers) was associated with a lower likelihood of lung cancer (OR=0.48, 95%CI=0.30-0.75, p=0.0015). Among lung cancer patients, smoking cessation was associated with a 7-year delay in median age of lung cancer diagnosis (HR=0.68, 95%CI=0.61-0.77, p=4.9∗10-10). The CHRNA5 rs16969968 risk genotype (AA) was associated with increased risk and earlier diagnosis for lung cancer, but the beneficial effects of smoking cessation were very similar in those with and without the risk genotype. CONCLUSION We demonstrate that quitting smoking is highly beneficial in reducing lung cancer risks for smokers regardless of their CHRNA5 rs16969968 genetic risk status. Smokers with high-risk CHRNA5 genotypes, on average, can largely eliminate their elevated genetic risk for lung cancer by quitting smoking- cutting their risk of lung cancer in half and delaying its onset by 7years for those who develop it. These results: 1) underscore the potential value of smoking cessation for all smokers, 2) suggest that CHRNA5 rs16969968 genotype affects lung cancer diagnosis through its effects on smoking, and 3) have potential value for framing preventive interventions for those who smoke.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Genetic risk can be decreased: Quitting smoking decreases and delays lung cancer for smokers with high and low CHRNA5 risk genotypes â•fl A meta-analysis

Genetic risk can be decreased: Quitting smoking decreases and delays lung cancer for smokers with high and low CHRNA5 risk genotypes — A meta-analysis. a b s t r a c t a r t i c l e i n f o Background: Recent meta-analyses show that individuals with high risk variants in CHRNA5 on chromosome 15q25 are likely to develop lung cancer earlier than those with low-risk genotypes. The same high-risk g...

متن کامل

Genetic Risk for Lung Cancer and the Benefits of Quitting Smoking

Article history: Received 16 August 2016 Accepted 16 August 2016 Available online 18 August 2016 lung cancer risk that is independent of behavior, and therefore, not influenced by quitting. The authors addressed this question using a meta-analytic approach involving 15 studies that examinedmore than 12,000 smokers (Chen et al., 2016). The study found that therewere no differences in the benefit...

متن کامل

CYP2A6 genetic polymorphism and its relation to risk of smoking dependence in male Iranians

Introduction: Nicotine is the psychoactive substance responsible for establishing and maintaining smoking dependence. CYP2A6 is the primary enzyme that inactivates nicotine to cotinine .Genetic variation in CYP2A6 accounts for some of the inter-individual variability in nicotine metabolism and has been indicated to influence smoking behavior and dependence. Therefore, the aim of this study was ...

متن کامل

CHRNA5 risk variant predicts delayed smoking cessation and earlier lung cancer diagnosis--a meta-analysis.

BACKGROUND Recent meta-analyses show strong evidence of associations among genetic variants in CHRNA5 on chromosome 15q25, smoking quantity, and lung cancer. This meta-analysis tests whether the CHRNA5 variant rs16969968 predicts age of smoking cessation and age of lung cancer diagnosis. METHODS Meta-analyses examined associations between rs16969968, age of quitting smoking, and age of lung c...

متن کامل

CHRNA5 polymorphisms and risk of lung cancer in Chinese Han smokers.

Lung cancer is the most frequent cancer among men in many countries. It is the result of interactions between genetic and environmental factors, among which tobacco smoking is a key environmental factor. CHRNA5, Cholinergic Receptor, Neuronal Nicotinic, Alpha Polypeptide-5, was previously reported to be associated with lung cancer risk. To identify the genetic susceptibility and tobacco smoking...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره 11  شماره 

صفحات  -

تاریخ انتشار 2016